$514 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 123 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDRX | New | GOODRX HLDGS INC | $5,669,410 | – | 1,007,000 | +100.0% | 1.10% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $4,751,742 | – | 180,195 | +100.0% | 0.92% | – |
| IOVA | New | IOVANCE BIOTHERAPEUT | $4,481,750 | – | 985,000 | +100.0% | 0.87% | – |
| ACAD | New | ACADIA PHARMACEUTCLS | $4,375,566 | – | 209,960 | +100.0% | 0.85% | – |
| PGNY | New | PROGYNY INC | $4,082,400 | – | 120,000 | +100.0% | 0.80% | – |
| RVMD | New | REVOLUTION MEDICIN | $3,948,552 | – | 142,650 | +100.0% | 0.77% | – |
| New | DOCGO INC | $3,471,962 | – | 651,400 | +100.0% | 0.68% | – | |
| ATEC | New | ALPHATEC HOLDINGS IN | $3,195,095 | – | 246,345 | +100.0% | 0.62% | – |
| New | VENTYX BIOSCIENCES I | $3,056,240 | – | 88,000 | +100.0% | 0.60% | – | |
| DXCM | New | DEXCOM INC | $2,957,610 | – | 31,700 | +100.0% | 0.58% | – |
| New | TURNSTONE BIOLOGICS | $2,039,533 | – | 517,648 | +100.0% | 0.40% | – | |
| STAA | New | STAAR SURGICAL CO | $1,888,460 | – | 47,000 | +100.0% | 0.37% | – |
| New | VERASTEM INC | $1,653,049 | – | 203,327 | +100.0% | 0.32% | – | |
| New | VERALTO CORPORATION | $309,320 | – | 3,658 | +100.0% | 0.06% | – | |
| EXEL | New | EXELIXIS INC | $272,688 | – | 12,480 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.